Renin-angiotensin-aldosterone system (RAAS) inhibitor, Atorvastatin calcium, Purity ≥98%

1-631-637-6119

Cat. No.: X24-09-YM294

Renin-angiotensin-aldosterone system (RAAS) inhibitor, Atorvastatin calcium, Purity ≥98%

Synonym: 134523-03-8; Lipitor; Sortis; Tahor; Atorvastatin calcium salt; Atorvastatin Hemicalcium; Atorvastatin hemicalcium salt; Atorvastatin calcium anhydrous; Rac-atorvastatin calcium; CI-981; Torvast; Calcium; (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate; Renin-angiotensin-aldosterone system (RAAS) inhibitor

MDL: MFCD00899261
CAS Number: 134523-03-8
Compound CID: 60822

Product Size

50 mg; 100 mg; 250 mg; 500 mg

Price

Datasheet

MSDS

Properties

Description

Atorvastatin calcium, soluble in DMSO and insoluble in water and ethanol, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting HMG-CoA reductase. The molecular weight of the compound is 1155.34, and its molecular formula is 2(C₃₃H₃₄FN₂O₅)·Ca.

Molecular Weight

1155.34

Molecular Formula

2(C₃₃H₃₄FN₂O₅)·Ca

Form

Lyophilized powder

Purity

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 92 mg/mL (79.63 mM); Water: insoluble; Ethanol: insoluble; In vivo: 2% DMSO + 35% PEG300 + 2% Tween 80 + ddH₂O, 3 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

Atorvastatin calcium can be used for its ability to lower LDL cholesterol and triglycerides by inhibiting HMG-CoA reductase.